Home › Kidney Failure › NCT06356168
Virtual Reality in End Stage Kidney Disease
Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria * Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month Exclusion Criteria * Acutely ill * Active nausea * Epilepsy
About the study
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
What is being tested
- Social Virtual Reality (behavioral)
- Individual Virtual Reality (behavioral)
Sponsor: University of Pennsylvania · Participants: 60 · Started: Mar 30, 2026
Contact the study team
- Lea Ann Matura, PhD · Phone: 2157468819
Official record on ClinicalTrials.gov — NCT06356168
Locations in the U.S.
| Pennsylvania | University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.